Evidence map›Paper›PMID 31021642›Full record

ArticleMolecular pharmaceutics2019

Electrospinning Optimization of Eudragit E PO with and without Chlorpheniramine Maleate Using a Design of Experiment Approach.

Hend E Abdelhakim, Alastair Coupe, Catherine Tuleu, Mohan Edirisinghe, Duncan Q M Craig

Open access · hybridAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hend E AbdelhakimSchool of Pharmacy , University College London (UCL) , 29-39 Brunswick Square , London WC1N 1AX , U.K.ORCID 0000-0002-8344-2431
Alastair CoupePfizer Limited, Global R&D , Discovery Park, Ramsgate Road , Sandwich , Kent CT13 9ND , U.K.
Catherine TuleuSchool of Pharmacy , University College London (UCL) , 29-39 Brunswick Square , London WC1N 1AX , U.K.
Mohan EdirisingheDepartment of Mechanical Engineering , UCL , Torrington Place , London WC1E 7JE , U.K.ORCID 0000-0001-8258-7914
Duncan Q M CraigSchool of Pharmacy , University College London (UCL) , 29-39 Brunswick Square , London WC1N 1AX , U.K.ORCID 0000-0003-1294-8993
Medway School of Pharmacy · GBPfizer (United Kingdom) · GBTorrington Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrospinning is increasingly becoming a viable means of producing drug delivery vehicles for oral delivery, particularly as issues of manufacturing scalability are being addressed. In this study, electrospinning is explored as a taste-masking manufacturing technology for bitter drugs. The taste-masking polymer Eudragit E PO (E-EPO) was electrospun, guided by a quality by design approach. Using a design of experiment, factors influencing the production of smooth fibers were investigated. Polymer concentration, solvent composition, applied voltage, flow rate, and gap distance were the parameters examined. Of these, polymer concentration was shown to be the only statistically significant factor within the ranges studied ( p-value = 0.0042). As the concentration increased, smoother fibers were formed, coupled with an increase in fiber diameter. E-EPO (35% w/v) was identified as the optimum concentration for smooth fiber production. The optimized processing conditions identified were a gap distance of 175 mm, an applied voltage of between 15 and 20 kV, and a flow rate of 1 mL/h. Using this knowledge, the production optimization of electrospun E-EPO with chlorpheniramine maleate (CPM), a bitter antihistamine drug, was explored. The addition of CPM in drug loads of 1:6 up to 1:10 CPM/E-EPO yielded smooth fibers that were electrospun under conditions similar to placebo fibers. Solid-state characterization showed CPM to be molecularly dispersed in E-EPO. An electronic tasting system, or E-tongue, indicated good taste-masking performance as compared to the equivalent physical mixtures. This study therefore describes a means of producing, optimizing, and assessing the performance of electrospun taste-masked fibers as a novel approach to the formulation of CPM and potentially other bitter drug substances.

Indexed as

Calorimetry, Differential ScanningChlorpheniramineHydrogen-Ion ConcentrationMicroscopy, Electron, ScanningPolymersPolymethacrylic AcidsSpectroscopy, Fourier Transform InfraredViscosityX-Ray DiffractionChlorpheniramineEudragit E POPolymersPolymethacrylic Acidschlorpheniramine maleateDoEelectrospinningE-tongueEudragit E POtaste-masking

Identifiers

PMID31021642
PMCPMC6549214
OpenAlexW2941003047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.